ARIPIPRAZOLE DIN 02506726
Health Canada record
| Active ingredient(s) | ARIPIPRAZOLE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AX12 ARIPIPRAZOLE |
| Original market date | 23-Apr-2021 |
| Current status date | 23-Apr-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sanis Health Inc. — licence 101796, currently licensed, last inspection rating I (2024-07-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ARIPIPRAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02322455 | ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02322412 | ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02322404 | ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02322374 | ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02322390 | ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02322382 | ABILIFY | OTSUKA PHARMACEUTICAL CO LTD | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02420864 | ABILIFY MAINTENA | OTSUKA PHARMACEUTICAL CO LTD | Kit; Powder For Suspension (Sustained-Release | ARIPIPRAZOLE 300 MG | Marketed |
| 02420872 | ABILIFY MAINTENA | OTSUKA PHARMACEUTICAL CO LTD | Kit; Powder For Suspension (Sustained-Release | ARIPIPRAZOLE 400 MG | Marketed |
| 02445018 | ABILIFY MAINTENA | OTSUKA PHARMACEUTICAL CO LTD | Powder For Suspension (Sustained-Release | ARIPIPRAZOLE 300 MG | Approved |
| 02445026 | ABILIFY MAINTENA | OTSUKA PHARMACEUTICAL CO LTD | Powder For Suspension (Sustained-Release | ARIPIPRAZOLE 400 MG | Approved |
| 02448173 | AG-ARIPIPRAZOLE | ANGITA PHARMA INC. | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02448181 | AG-ARIPIPRAZOLE | ANGITA PHARMA INC. | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02448203 | AG-ARIPIPRAZOLE | ANGITA PHARMA INC. | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02448211 | AG-ARIPIPRAZOLE | ANGITA PHARMA INC. | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02448238 | AG-ARIPIPRAZOLE | ANGITA PHARMA INC. | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02448246 | AG-ARIPIPRAZOLE | ANGITA PHARMA INC. | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02471086 | APO-ARIPIPRAZOLE | APOTEX INC | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02471094 | APO-ARIPIPRAZOLE | APOTEX INC | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02471108 | APO-ARIPIPRAZOLE | APOTEX INC | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02471116 | APO-ARIPIPRAZOLE | APOTEX INC | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02471124 | APO-ARIPIPRAZOLE | APOTEX INC | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02471132 | APO-ARIPIPRAZOLE | APOTEX INC | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02460025 | AURO-ARIPIPRAZOLE | AURO PHARMA INC | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02460084 | AURO-ARIPIPRAZOLE | AURO PHARMA INC | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02460076 | AURO-ARIPIPRAZOLE | AURO PHARMA INC | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02460068 | AURO-ARIPIPRAZOLE | AURO PHARMA INC | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02460041 | AURO-ARIPIPRAZOLE | AURO PHARMA INC | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02460033 | AURO-ARIPIPRAZOLE | AURO PHARMA INC | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02472279 | NRA-ARIPIPRAZOLE | NORA PHARMA INC | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02472260 | NRA-ARIPIPRAZOLE | NORA PHARMA INC | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02472252 | NRA-ARIPIPRAZOLE | NORA PHARMA INC | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02472244 | NRA-ARIPIPRAZOLE | NORA PHARMA INC | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02472228 | NRA-ARIPIPRAZOLE | NORA PHARMA INC | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02472201 | NRA-ARIPIPRAZOLE | NORA PHARMA INC | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02466643 | PMS-ARIPIPRAZOLE | PHARMASCIENCE INC | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02466686 | PMS-ARIPIPRAZOLE | PHARMASCIENCE INC | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02466635 | PMS-ARIPIPRAZOLE | PHARMASCIENCE INC | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02466651 | PMS-ARIPIPRAZOLE | PHARMASCIENCE INC | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02466678 | PMS-ARIPIPRAZOLE | PHARMASCIENCE INC | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02466694 | PMS-ARIPIPRAZOLE | PHARMASCIENCE INC | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02479346 | RIVA-ARIPIPRAZOLE | LABORATOIRE RIVA INC. | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02479354 | RIVA-ARIPIPRAZOLE | LABORATOIRE RIVA INC. | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02473690 | SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 20 MG | Marketed |
| 02473658 | SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 2 MG | Marketed |
| 02473666 | SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 5 MG | Marketed |
| 02473674 | SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 10 MG | Marketed |
| 02473682 | SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 15 MG | Marketed |
| 02473704 | SANDOZ ARIPIPRAZOLE | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 30 MG | Marketed |
| 02475138 | SANDOZ ARIPIPRAZOLE TABLET | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 20 MG | Cancelled Pre Market |
| 02475073 | SANDOZ ARIPIPRAZOLE TABLET | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 2 MG | Cancelled Pre Market |
| 02475081 | SANDOZ ARIPIPRAZOLE TABLET | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 5 MG | Cancelled Pre Market |
| 02475103 | SANDOZ ARIPIPRAZOLE TABLET | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 10 MG | Cancelled Pre Market |
| 02475111 | SANDOZ ARIPIPRAZOLE TABLET | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 15 MG | Cancelled Pre Market |
| 02475146 | SANDOZ ARIPIPRAZOLE TABLET | SANDOZ CANADA INCORPORATED | Tablet | ARIPIPRAZOLE 30 MG | Cancelled Pre Market |
| 02464144 | TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Tablet | ARIPIPRAZOLE 2 MG | Cancelled Post Market |
| 02464179 | TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Tablet | ARIPIPRAZOLE 15 MG | Cancelled Post Market |
| 02464195 | TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Tablet | ARIPIPRAZOLE 30 MG | Cancelled Post Market |
| 02464187 | TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Tablet | ARIPIPRAZOLE 20 MG | Cancelled Post Market |
| 02464160 | TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Tablet | ARIPIPRAZOLE 10 MG | Cancelled Post Market |
| 02464152 | TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Tablet | ARIPIPRAZOLE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24462 | 2020-10-19 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for ARIPIPRAZOLE
14 valid EDQM Certificates of Suitability from 14 holders. 54 active FDA Drug Master Files.
Request a quote for ARIPIPRAZOLE